ID   2A9 [Mouse hybridoma against human MBL2]
AC   CVCL_B0JX
DR   Wikidata; Q108819510
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
RX   PubMed=11991814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12620.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
RX   PubMed=11991814; DOI=10.1089/15368590252917610;
RA   Zhao, Hui
RA   Wakamiya, Nobutaka
RA   Suzuki, Yasuhiko
RA   Hamonko, Matthew T.
RA   Stahl, Gregory L.
RT   "Identification of human mannose binding lectin (MBL) recognition
RT   sites for novel inhibitory antibodies.";
RL   Hybrid. Hybridomics 21:25-36(2002).
//
RX   Patent=WO2000035483A1;
RA   Stahl, Gregory L.
RA   Collard, Charles David
RT   "Methods and products for regulating lectin complement pathway
RT   associated complement activation.";
RL   Patent number WO2000035483A1, 22-Jun-2000.
//
RX   PubMed=10793066; DOI=10.1016/S0002-9440(10)65026-2; PMCID=PMC1876913;
RA   Collard, Charles David
RA   Vakeva, Antti
RA   Morrissey, Margaret A.
RA   Agah, Azin
RA   Rollins, Scott A.
RA   Reenstra, Wende R.
RA   Buras, Jon A.
RA   Meri, Seppo
RA   Stahl, Gregory L.
RT   "Complement activation after oxidative stress: role of the lectin
RT   complement pathway.";
RL   Am. J. Pathol. 156:1549-1556(2000).
//